Recent patents on treatment of severe acute respiratory syndrome (SARS).
Identifieur interne : 003620 ( Main/Exploration ); précédent : 003619; suivant : 003621Recent patents on treatment of severe acute respiratory syndrome (SARS).
Auteurs : Shumei Zhai [République populaire de Chine] ; Wei Liu ; Bing YanSource :
- Recent patents on anti-infective drug discovery [ 1574-891X ] ; 2007.
Descripteurs français
- KwdFr :
- Animaux, Antiviraux (usage thérapeutique), Brevets comme sujet, Cysteine endopeptidases, Humains, Inhibiteurs de protéases (usage thérapeutique), Petit ARN interférent (pharmacologie), Petit ARN interférent (usage thérapeutique), Protéines virales (antagonistes et inhibiteurs), Réplication virale (), Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (traitement médicamenteux), Syndrome respiratoire aigu sévère (virologie), Vaccins antiviraux (usage thérapeutique), Virus du SRAS (), Virus du SRAS (génétique).
- MESH :
- antagonistes et inhibiteurs : Protéines virales.
- génétique : Virus du SRAS.
- pharmacologie : Petit ARN interférent.
- traitement médicamenteux : Syndrome respiratoire aigu sévère.
- usage thérapeutique : Antiviraux, Inhibiteurs de protéases, Petit ARN interférent, Vaccins antiviraux.
- virologie : Syndrome respiratoire aigu sévère.
- Animaux, Brevets comme sujet, Cysteine endopeptidases, Humains, Réplication virale, Syndrome respiratoire aigu sévère, Virus du SRAS.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (therapeutic use), Cysteine Endopeptidases, Humans, Patents as Topic, Protease Inhibitors (therapeutic use), RNA, Small Interfering (pharmacology), RNA, Small Interfering (therapeutic use), SARS Virus (drug effects), SARS Virus (genetics), Severe Acute Respiratory Syndrome (drug therapy), Severe Acute Respiratory Syndrome (prevention & control), Severe Acute Respiratory Syndrome (virology), Viral Proteins (antagonists & inhibitors), Viral Vaccines (therapeutic use), Virus Replication (drug effects).
- MESH :
- chemical , antagonists & inhibitors : Viral Proteins.
- chemical , pharmacology : RNA, Small Interfering.
- chemical , therapeutic use : Antiviral Agents, Protease Inhibitors, RNA, Small Interfering, Viral Vaccines.
- drug effects : SARS Virus, Virus Replication.
- drug therapy : Severe Acute Respiratory Syndrome.
- genetics : SARS Virus.
- prevention & control : Severe Acute Respiratory Syndrome.
- virology : Severe Acute Respiratory Syndrome.
- Animals, Cysteine Endopeptidases, Humans, Patents as Topic.
Abstract
Severe acute respiratory syndrome (SARS) is an epidemic that spread worldwide in early 2003. The aetiological agent was originally defined as a novel coronavirus and later designated as the SARS coronavirus (SARS-CoV), which appears similar to other coronaviruses in both virion structure and genome organization with a single-stranded, plus-sense RNA. However, the epidemiology and pathogenesis of SARS remain poorly understood and there is currently no effective treatment. To date, considerable research has been done on detection, prevention and treatment of SARS. In this review, we mainly focus on the recent patents and research work on detecting, preventing and treating SARS.
DOI: 10.2174/157489107779561698
PubMed: 18221160
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001C30
- to stream PubMed, to step Curation: 001C30
- to stream PubMed, to step Checkpoint: 001D21
- to stream Ncbi, to step Merge: 001B62
- to stream Ncbi, to step Curation: 001B62
- to stream Ncbi, to step Checkpoint: 001B62
- to stream Main, to step Merge: 003747
- to stream Main, to step Curation: 003620
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recent patents on treatment of severe acute respiratory syndrome (SARS).</title><author><name sortKey="Zhai, Shumei" sort="Zhai, Shumei" uniqKey="Zhai S" first="Shumei" last="Zhai">Shumei Zhai</name><affiliation wicri:level="1"><nlm:affiliation>School of Pharmaceutical Sciences and Institute of Environmental Sciences, Shandong University, Jinan, Shandong, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>School of Pharmaceutical Sciences and Institute of Environmental Sciences, Shandong University, Jinan, Shandong</wicri:regionArea><wicri:noRegion>Shandong</wicri:noRegion></affiliation></author><author><name sortKey="Liu, Wei" sort="Liu, Wei" uniqKey="Liu W" first="Wei" last="Liu">Wei Liu</name></author><author><name sortKey="Yan, Bing" sort="Yan, Bing" uniqKey="Yan B" first="Bing" last="Yan">Bing Yan</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:18221160</idno><idno type="pmid">18221160</idno><idno type="doi">10.2174/157489107779561698</idno><idno type="wicri:Area/PubMed/Corpus">001C30</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C30</idno><idno type="wicri:Area/PubMed/Curation">001C30</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001C30</idno><idno type="wicri:Area/PubMed/Checkpoint">001D21</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001D21</idno><idno type="wicri:Area/Ncbi/Merge">001B62</idno><idno type="wicri:Area/Ncbi/Curation">001B62</idno><idno type="wicri:Area/Ncbi/Checkpoint">001B62</idno><idno type="wicri:doubleKey">1574-891X:2007:Zhai S:recent:patents:on</idno><idno type="wicri:Area/Main/Merge">003747</idno><idno type="wicri:Area/Main/Curation">003620</idno><idno type="wicri:Area/Main/Exploration">003620</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Recent patents on treatment of severe acute respiratory syndrome (SARS).</title><author><name sortKey="Zhai, Shumei" sort="Zhai, Shumei" uniqKey="Zhai S" first="Shumei" last="Zhai">Shumei Zhai</name><affiliation wicri:level="1"><nlm:affiliation>School of Pharmaceutical Sciences and Institute of Environmental Sciences, Shandong University, Jinan, Shandong, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>School of Pharmaceutical Sciences and Institute of Environmental Sciences, Shandong University, Jinan, Shandong</wicri:regionArea><wicri:noRegion>Shandong</wicri:noRegion></affiliation></author><author><name sortKey="Liu, Wei" sort="Liu, Wei" uniqKey="Liu W" first="Wei" last="Liu">Wei Liu</name></author><author><name sortKey="Yan, Bing" sort="Yan, Bing" uniqKey="Yan B" first="Bing" last="Yan">Bing Yan</name></author></analytic><series><title level="j">Recent patents on anti-infective drug discovery</title><idno type="ISSN">1574-891X</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antiviral Agents (therapeutic use)</term><term>Cysteine Endopeptidases</term><term>Humans</term><term>Patents as Topic</term><term>Protease Inhibitors (therapeutic use)</term><term>RNA, Small Interfering (pharmacology)</term><term>RNA, Small Interfering (therapeutic use)</term><term>SARS Virus (drug effects)</term><term>SARS Virus (genetics)</term><term>Severe Acute Respiratory Syndrome (drug therapy)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Viral Proteins (antagonists & inhibitors)</term><term>Viral Vaccines (therapeutic use)</term><term>Virus Replication (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antiviraux (usage thérapeutique)</term><term>Brevets comme sujet</term><term>Cysteine endopeptidases</term><term>Humains</term><term>Inhibiteurs de protéases (usage thérapeutique)</term><term>Petit ARN interférent (pharmacologie)</term><term>Petit ARN interférent (usage thérapeutique)</term><term>Protéines virales (antagonistes et inhibiteurs)</term><term>Réplication virale ()</term><term>Syndrome respiratoire aigu sévère ()</term><term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Vaccins antiviraux (usage thérapeutique)</term><term>Virus du SRAS ()</term><term>Virus du SRAS (génétique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Viral Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>RNA, Small Interfering</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term><term>Protease Inhibitors</term><term>RNA, Small Interfering</term><term>Viral Vaccines</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Protéines virales</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term><term>Virus Replication</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Petit ARN interférent</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term><term>Inhibiteurs de protéases</term><term>Petit ARN interférent</term><term>Vaccins antiviraux</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cysteine Endopeptidases</term><term>Humans</term><term>Patents as Topic</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Brevets comme sujet</term><term>Cysteine endopeptidases</term><term>Humains</term><term>Réplication virale</term><term>Syndrome respiratoire aigu sévère</term><term>Virus du SRAS</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) is an epidemic that spread worldwide in early 2003. The aetiological agent was originally defined as a novel coronavirus and later designated as the SARS coronavirus (SARS-CoV), which appears similar to other coronaviruses in both virion structure and genome organization with a single-stranded, plus-sense RNA. However, the epidemiology and pathogenesis of SARS remain poorly understood and there is currently no effective treatment. To date, considerable research has been done on detection, prevention and treatment of SARS. In this review, we mainly focus on the recent patents and research work on detecting, preventing and treating SARS.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><noCountry><name sortKey="Liu, Wei" sort="Liu, Wei" uniqKey="Liu W" first="Wei" last="Liu">Wei Liu</name><name sortKey="Yan, Bing" sort="Yan, Bing" uniqKey="Yan B" first="Bing" last="Yan">Bing Yan</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="Zhai, Shumei" sort="Zhai, Shumei" uniqKey="Zhai S" first="Shumei" last="Zhai">Shumei Zhai</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003620 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003620 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:18221160
|texte= Recent patents on treatment of severe acute respiratory syndrome (SARS).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18221160" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |